Literature DB >> 14553963

beta-Adducin polymorphisms, blood pressure, and sodium excretion in three European populations.

Valérie Tikhonoff1, Tatiana Kuznetsova, Katarzyna Stolarz, Giuseppe Bianchi, Edoardo Casiglia, Kalina Kawecka-Jaszcz, Yuri Nikitin, Laura Tizzone, Ji Guang Wang, Jan A Staessen.   

Abstract

The associations of the beta-adducin C1797T polymorphism with blood pressure (BP) and various indexes of sodium homeostasis were investigated in 388 men and 456 women, aged 18 to 60 years, recruited from three European populations (Cracow, Poland, n = 300; Novosibirsk, Russian Federation, n = 274; Mirano, Italy; n = 270). Phenotypes included 24-h ambulatory BP and urinary excretion of electrolytes and aldosterone. Subjects were genotyped for the beta-adducin polymorphism. Both a population-based association study and a family-based analysis were performed. Urinary sodium excretion was higher in Cracow than in Mirano (241 v 185 mmol/24 h, P <.05) and intermediate in Novosibirsk (206 mmol/24 h). The beta-adducin T allele (15.2% v 9.1%, P <.0001) was more prevalent in Mirano than in the two Slavic centers. In both population-based and family-based association analyses, there was significant heterogeneity between Slavic and Italian subjects in the phenotype-genotype relationships with beta-adducin. In the Slavic centers, 24-h systolic BP was higher in T allele carriers than in CC homozygotes (122.3 v 119.7 mm Hg, P =.03), whereas this was not the case in Mirano (121.8 v 122.9 mm Hg, P =.42). In Slavic (212.6 v 233.1 mmol/24 h) as well as in Italian (166.1 v 191.5 mmol/24 h) participants, 24-h sodium excretion was lower (P =.01) in T allele carriers than in CC homozygotes. These results were confirmed in the family-based analysis of offspring using a quantitative transmission disequilibrium test. In conclusion, the frequency of the beta-adducin T allele and salt intake differ across European populations. Thus, both variation in genetic background and salt intake may explain the observed heterogeneity in the phenotype-genotype relationships. Genetic determinants of complex quantitative traits such as BP can only be investigated within their epidemiologic context.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14553963     DOI: 10.1016/s0895-7061(03)00975-0

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  8 in total

Review 1.  Between candidate genes and whole genomes: time for alternative approaches in blood pressure genetics.

Authors:  Jacob Basson; Jeannette Simino; D C Rao
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

2.  Old-style epidemiology and epigeneticdemiology.

Authors:  Edoardo Casiglia; Valérie Tikhonoff
Journal:  Hypertens Res       Date:  2015-03-26       Impact factor: 3.872

Review 3.  Genetics of salt-sensitive hypertension.

Authors:  Hironobu Sanada; John E Jones; Pedro A Jose
Journal:  Curr Hypertens Rep       Date:  2011-02       Impact factor: 5.369

Review 4.  Genetics of arterial hypertension and hypotension.

Authors:  Dieter Rosskopf; Markus Schürks; Christian Rimmbach; Rafael Schäfers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-30       Impact factor: 3.000

5.  Main results of the ouabain and adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxin.

Authors:  Jan A Staessen; Lutgarde Thijs; Katarzyna Stolarz-Skrzypek; Antonella Bacchieri; John Barton; Ezio Degli Espositi; Peter W de Leeuw; Mirosław Dłużniewski; Nicola Glorioso; Andrzej Januszewicz; Paolo Manunta; Viktor Milyagin; Yuri Nikitin; Miroslav Souček; Chiara Lanzani; Lorena Citterio; Mario Timio; Andrzej Tykarski; Patrizia Ferrari; Giovanni Valentini; Kalina Kawecka-Jaszcz; Giuseppe Bianchi
Journal:  Trials       Date:  2011-01-14       Impact factor: 2.279

6.  Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study.

Authors:  Edoardo Casiglia; Valérie Tikhonoff; Agostino Virdis; Stefano Masi; Carlo M Barbagallo; Michele Bombelli; Bernardino Bruno; Arrigo F G Cicero; Massimo Cirillo; Pietro Cirillo; Giovambattista Desideri; Lanfranco D'Elia; Claudio Ferri; Ferruccio Galletti; Loreto Gesualdo; Cristina Giannattasio; Guido Iaccarino; Luciano Lippa; Francesca Mallamaci; Alessandro Maloberti; Alberto Mazza; Maria Lorenza Muiesan; Pietro Nazzaro; Paolo Palatini; Gianfranco Parati; Roberto Pontremoli; Fosca Quarti-Trevano; Marcello Rattazzi; Giulia Rivasi; Massimo Salvetti; Giuliano Tocci; Andrea Ungar; Paolo Verdecchia; Francesca Viazzi; Massimo Volpe; Guido Grassi; Claudio Borghi
Journal:  J Hypertens       Date:  2020-03       Impact factor: 4.776

7.  Interactions between the adducin 2 gene and antihypertensive drug therapies in determining blood pressure in people with hypertension.

Authors:  Sharon L R Kardia; Yan V Sun; Sara C Hamon; Ruth Ann Barkley; Eric Boerwinkle; Stephen T Turner
Journal:  BMC Med Genet       Date:  2007-09-13       Impact factor: 2.103

Review 8.  A Review on Adducin from Functional to Pathological Mechanisms: Future Direction in Cancer.

Authors:  Karrie Mei-Yee Kiang; Gilberto Ka-Kit Leung
Journal:  Biomed Res Int       Date:  2018-05-16       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.